Anti-PKD2/ APKD2/ PC2 monoclonal antibody

Anti-PKD2/ APKD2/ PC2 antibody for FACS & in-vivo assay

Target products collectionGo to PKD2/PKD2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1376-Ab-1/ GM-Tg-hg-MP1376-Ab-2Anti-Human PKD2 monoclonal antibodyHuman
GM-Tg-rg-MP1376-Ab-1/ GM-Tg-rg-MP1376-Ab-2Anti-Rat PKD2 monoclonal antibodyRat
GM-Tg-mg-MP1376-Ab-1/ GM-Tg-mg-MP1376-Ab-2Anti-Mouse PKD2 monoclonal antibodyMouse
GM-Tg-cynog-MP1376-Ab-1/ GM-Tg-cynog-MP1376-Ab-2Anti-Cynomolgus/ Rhesus macaque PKD2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1376-Ab-1/ GM-Tg-felg-MP1376-Ab-2Anti-Feline PKD2 monoclonal antibodyFeline
GM-Tg-cang-MP1376-Ab-1/ GM-Tg-cang-MP1376-Ab-2Anti-Canine PKD2 monoclonal antibodyCanine
GM-Tg-bovg-MP1376-Ab-1/ GM-Tg-bovg-MP1376-Ab-2Anti-Bovine PKD2 monoclonal antibodyBovine
GM-Tg-equg-MP1376-Ab-1/ GM-Tg-equg-MP1376-Ab-2Anti-Equine PKD2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1376-Ab-1/ GM-Tg-hg-MP1376-Ab-2; GM-Tg-rg-MP1376-Ab-1/ GM-Tg-rg-MP1376-Ab-2;
GM-Tg-mg-MP1376-Ab-1/ GM-Tg-mg-MP1376-Ab-2; GM-Tg-cynog-MP1376-Ab-1/ GM-Tg-cynog-MP1376-Ab-2;
GM-Tg-felg-MP1376-Ab-1/ GM-Tg-felg-MP1376-Ab-2; GM-Tg-cang-MP1376-Ab-1/ GM-Tg-cang-MP1376-Ab-2;
GM-Tg-bovg-MP1376-Ab-1/ GM-Tg-bovg-MP1376-Ab-2; GM-Tg-equg-MP1376-Ab-1/ GM-Tg-equg-MP1376-Ab-2
Products NameAnti-PKD2 monoclonal antibody
Formatmab
Target NamePKD2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PKD2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PKD2/ APKD2/ PC2 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMAD000004human PKD2 Adenovirus plasmid
    ORF Viral VectorvGMAD000004human PKD2 Adenovirus particle


    Target information

    Target IDGM-MP1376
    Target NamePKD2
    Gene ID5311,18764,498328,702179,487852,101098948,530393,100063439
    Gene Symbol and SynonymsAPKD2,C030034P18Rik,Pc-2,PC2,PKD2,PKD4,RGD1559992,TRPP2
    Uniprot AccessionQ13563,Q4GZT3
    Uniprot Entry NamePKD2_HUMAN,PKD2_BOVIN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000118762
    Target ClassificationTumor-associated antigen (TAA)

    The target: PKD2, gene name: PKD2, also named as APKD2, PC2, PKD4, Pc-2, TRPP2. This gene encodes a member of the polycystin protein family. The encoded protein is a multi-pass membrane protein that functions as a calcium permeable cation channel, and is involved in calcium transport and calcium signaling in renal epithelial cells. This protein interacts with polycystin 1, and they may be partners in a common signaling cascade involved in tubular morphogenesis. Mutations in this gene are associated with autosomal dominant polycystic kidney disease type 2. [provided by RefSeq, Mar 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.